Graded management of patients with heart failure and primary prevention of sudden death from heart failure

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1800018942

Enrollment

Unknown

Registered

2018-10-17

Start date

2019-01-01

Completion date

Unknown

Last updated

2018-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure

Interventions

Case series:Nil

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. The age is between 20and 80 years old; 2. Definitive diagnosis of chronic heart failure, echocardiography or left ventricular angiography or isotope scan showed LVEF = 50%, after long-term optimized drug treatment, NYHA grading is still II or III.

Exclusion criteria

Exclusion criteria: 1. Patients with ischemic heart disease have MI<40 days; 2. A history of cardiac arrest, ventricular fibrillation, and ventricular tachycardia with hemodynamic instability; CABG or PCI revascularization within 3.2 months; 4. Women of childbearing age who use contraceptives; 5. Combined with severe cerebrovascular disease; 6. Combined with increased mortality of patients during the experimental observation period (except patients who used cardiotonic agents); 7. Patients participating in other clinical trials.

Design outcomes

Primary

Measure	Time frame
risk factors of SCD;	—

Countries

China

Contacts

Public ContactWang Fang

Shanghai General Hospital

onlyfang1@163.com+86 13621950918

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026